IP Verse

Compositions, Methods And Systems For Aerosol Drug Delivery - EP4175619

The patent EP4175619 was granted to Astrazeneca Pharmaceuticals LP on Apr 10, 2024. The application was originally filed on Jul 8, 2022 under application number EP22748656A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4175619

ASTRAZENECA PHARMACEUTICALS LP
Application Number
EP22748656A
Filing Date
Jul 8, 2022
Status
Granted And Under Opposition
Mar 8, 2024
Grant Date
Apr 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BRAND MURRAY FULLERJan 10, 2025ADMISSIBLE
ELKINGTON AND FIFEJan 9, 2025ADMISSIBLE

Patent Citations (60) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2008125407
DESCRIPTIONUS2011135737
DESCRIPTIONUS2956062
DESCRIPTIONUS3705233
DESCRIPTIONUS37872
DESCRIPTIONUS3929768
DESCRIPTIONUS3994974
DESCRIPTIONUS4187301
DESCRIPTIONUS4335121
DESCRIPTIONUS4472393
DESCRIPTIONUS4992474
DESCRIPTIONUS5126375
DESCRIPTIONUS5225445
DESCRIPTIONUS5610163
DESCRIPTIONUS5684199
DESCRIPTIONUS5707634
DESCRIPTIONUS5833891
DESCRIPTIONUS5851453
DESCRIPTIONUS5858410
DESCRIPTIONUS5886200
DESCRIPTIONUS5889015
DESCRIPTIONUS5928469
DESCRIPTIONUS6040344
DESCRIPTIONUS6057307
DESCRIPTIONUS6057581
DESCRIPTIONUS6063138
DESCRIPTIONUS6177560
DESCRIPTIONUS6258341
DESCRIPTIONUS6309623
DESCRIPTIONUS6309671
DESCRIPTIONUS6358530
DESCRIPTIONUS6365581
DESCRIPTIONUS6372258
DESCRIPTIONUS6518239
DESCRIPTIONUS6677322
DESCRIPTIONUS6677323
DESCRIPTIONUS6777423
DESCRIPTIONUS6908928
DESCRIPTIONUS7442388
DESCRIPTIONUS8604064
DESCRIPTIONUS8815258
DESCRIPTIONUS9145365
DESCRIPTIONUS9321726
DESCRIPTIONUS9463161
DESCRIPTIONUSRE39820E
DESCRIPTIONWO2005000267
DESCRIPTIONWO2007009164
DESCRIPTIONWO2010138862
DESCRIPTIONWO2010138868
DESCRIPTIONWO2010138884
DESCRIPTIONWO2019074799
DESCRIPTIONWO9505805
DESCRIPTIONWO9632149
INTERNATIONAL-SEARCH-REPORTUS2012039817
INTERNATIONAL-SEARCH-REPORTWO2014190204
OPPOSITIONEP2228421
OPPOSITIONUS2006269484
OPPOSITIONUS2012039817
OPPOSITIONUS2016324778
OPPOSITIONWO2014190204

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers", (20220222), URL: https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2022/astrazeneca-progresses-ambition-zero-carbon-programme-with-honeywell-partnership-to-develop-next-generation-respiratory-inhalers.html#!, (20220916), XP055961867-
OPPOSITION- Anonymous, "BEVESPI AEROSPHERE - HIGHLIGHTS OF PRESCRIBING INFORMATION ", FDA, (20201101), FDA, URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208294s009lbl.pdf, XP093254633-
OPPOSITION- Anonymous, "BREZTRI AEROSPHERE - HIGHLIGHTS OF PRESCRIBING INFORMATION ", FDA, (20200701), pages 1 - 44, XP093254639-
OPPOSITION- Anonymous, "Highlights of Prescribing Information for VENTOLIN HFA (albuterol sulfate) Inhalation Aerosol", URL: https://www.google.nl/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwiCx_W-gIDZAhXEaVAKHRYhDUcQFgguMAA&url=https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Ventolin_HFA/pdf/VENTOLIN-HFA-PI-PIL.PDF&usg=AOvVaw2qAXQitn6_onDJPtzUDDxI, (20180130), XP055446266-
OPPOSITION- Anonymous Honeywell, "Honeywell Solstice Propellant", Honeywell Technical Bulletin, (20120101), pages 1 - 4, XP093253761-
OPPOSITION- Anonymous, "Solstice™ 1234ze - Material Safety Data Sheet", Honeywell; Version 2, (20120425), XP093252885-
OPPOSITION- D10 - T0805/14-
OPPOSITION- D11 - Patentee’s grounds of appeal in T0805/14-
OPPOSITION- D7 - Declaration of Dr George Rusch, 8 July 2010-
OPPOSITION- Michael Hindle, "5.8 Aerosol drug delivery", Michael Hindle, Shayne Cox Gad (Editor), Pharmaceutical manufacturing handbook: production and processes, Hoboken, New Jersey , John Wiley & Sons, Inc , (20080101), pages 683 - 727, ISBN 978-0-470-25958-0, XP009559743-
OPPOSITION- Ferguson Gary T., Hickey Anthony J., Dwivedi Sarvajna, "Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases", Respiratory Medicine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20180101), vol. 134, doi:10.1016/j.rmed.2017.09.012, ISSN 0954-6111, pages 16 - 23, XP093253842
OPPOSITION- Myrdal Paul B., Sheth Poonam, Stein Stephen W., "Advances in Metered Dose Inhaler Technology: Formulation Development", AAPS PharmSciTech, (20140401), vol. 15, no. 2, doi:10.1208/s12249-013-0063-x, pages 434 - 455, XP055795960
OPPOSITION- Usmani Omar S, Roche Nicolas, Jenkins Martin, Stjepanovic Neda, Mack Peter, De Backer Wilfried, "Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence", The International journal of chronic obstructive pulmonary disease, Albany, Auckland : DOVE Medical Press, (20210101), vol. 16, doi:10.2147/COPD.S274846, ISSN 1178-2005, pages 113 - 124, XP093253846
OPPOSITION- Pritchard John N, "The Climate is Changing for Metered-Dose Inhalers and Action is Needed", Drug Design, Development and Therapy, (20200101), Volume 14, doi:10.2147/DDDT.S262141, pages 3043 - 3055, XP055795957

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents